ストックスクリーナーアプリを入手
58.36
3.86%
2.17
アフターアワーズ：
58.36
前日終値:
$56.19
開ける：
$56.5
24時間の取引高:
1.45M
Relative Volume:
1.76
時価総額：
$3.63B
収益：
$45.48M
当期純損益:
$169.95M
株価収益率:
22.27
EPS:
2.62
ネットキャッシュフロー:
$230.85M
1週間 パフォーマンス:
-0.83%
1か月 パフォーマンス:
+14.27%
6か月 パフォーマンス:
+52.18%
1年 パフォーマンス:
+30.88%
1日の値動き範囲:
$54.50
$59.31
1週間の範囲:
$54.50
$61.04
52週間の値動き範囲:
$33.31
$61.89
Protagonist Therapeutics Inc Stock (PTGX) Company Profile
名前
Protagonist Therapeutics Inc
セクター
電話
(510) 474-0170
住所
7707 GATEWAY BLVD., SUITE 140, NEWARK, CA
PTGX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PTGX
Protagonist Therapeutics Inc
|
58.36 | 3.50B | 45.48M | 169.95M | 230.85M | 2.62 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.48 | 101.34B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
482.13 | 59.64B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
556.53 | 59.19B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
767.00 | 47.00B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
351.13 | 38.12B | 3.81B | -644.79M | -669.77M | -6.24 |
Protagonist Therapeutics Inc Stock (PTGX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-06-17 | 開始されました | Citigroup | Buy |
| 2024-12-06 | 開始されました | BMO Capital Markets | Outperform |
| 2024-12-06 | 開始されました | Goldman | Neutral |
| 2024-11-05 | 開始されました | Wedbush | Outperform |
| 2024-09-24 | 開始されました | TD Cowen | Buy |
| 2024-09-09 | 開始されました | Truist | Buy |
| 2023-10-30 | 開始されました | CapitalOne | Overweight |
| 2023-05-25 | 再開されました | Jefferies | Buy |
| 2022-08-25 | 開始されました | JMP Securities | Mkt Outperform |
| 2022-02-11 | 開始されました | BTIG Research | Buy |
| 2021-10-12 | アップグレード | JP Morgan | Neutral → Overweight |
| 2021-10-11 | アップグレード | Northland Capital | Market Perform → Outperform |
| 2021-09-20 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2021-05-24 | 開始されました | JMP Securities | Mkt Outperform |
| 2021-05-24 | 開始されました | Northland Capital | Outperform |
| 2021-01-06 | 開始されました | JP Morgan | Overweight |
| 2020-12-16 | 開始されました | Piper Sandler | Overweight |
| 2020-09-18 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-07-15 | 開始されました | Jefferies | Buy |
| 2020-05-18 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-07-08 | 開始されました | H.C. Wainwright | Buy |
| 2019-05-09 | アップグレード | Stifel | Hold → Buy |
| 2018-12-06 | 開始されました | Nomura | Buy |
| 2018-01-29 | 開始されました | Stifel | Buy |
| 2017-07-21 | 開始されました | BTIG Research | Buy |
すべてを表示
Protagonist Therapeutics Inc (PTGX) 最新ニュース
Will Protagonist Therapeutics Inc. Hold Gains Into CloseInsider Buying & Risk Controlled Stock Alerts - beatles.ru
Those Who Invested in Protagonist Therapeutics (NASDAQ:PTGX) Three Years Ago Are up 573% - 富途牛牛
Will Protagonist Therapeutics Inc. benefit from geopolitical trends2025 Technical Patterns & Long Hold Capital Preservation Plans - beatles.ru
Protagonist Therapeutics’ PN-881 Study: A Closer Look at Market Implications - TipRanks
Applying Wyckoff theory to Protagonist Therapeutics Inc. stock2025 Biggest Moves & Safe Swing Trade Setups - Newser
Is Protagonist Therapeutics Inc. a cyclical or defensive stock2025 Risk Factors & Real-Time Sentiment Analysis - خودرو بانک
What is Protagonist Therapeutics Inc. s revenue forecastJuly 2025 Short Interest & High Return Trade Guides - خودرو بانک
Aug Levels: Is Protagonist Therapeutics Inc. in a bullish channelEarnings Recap Report & Weekly High Return Stock Opportunities - classian.co.kr
Institutional scanner results for Protagonist Therapeutics Inc.July 2025 Outlook & Community Supported Trade Ideas - Newser
Live market analysis of Protagonist Therapeutics Inc.Bull Run & Fast Momentum Entry Tips - Newser
What’s the recovery path for long term holders of Protagonist Therapeutics Inc.July 2025 Weekly Recap & High Accuracy Investment Signals - Newser
Can Protagonist Therapeutics Inc. expand into new markets2025 Fundamental Recap & Reliable Price Breakout Signals - خودرو بانک
Is Protagonist Therapeutics Inc. affected by consumer sentiment2025 Volume Leaders & AI Driven Stock Reports - خودرو بانک
Custom watchlist performance reports with Protagonist Therapeutics Inc.July 2025 Review & Reliable Momentum Entry Alerts - Newser
Can volume confirm reversal in Protagonist Therapeutics Inc.2025 Investor Takeaways & Risk Managed Trade Strategies - Newser
Will Protagonist Therapeutics Inc. benefit from rate cutsCPI Data & Technical Pattern Recognition Alerts - خودرو بانک
Is Protagonist Therapeutics Inc. vulnerable to short sellers2025 EndofYear Setup & Entry Point Confirmation Signals - خودرو بانک
Is Protagonist Therapeutics Inc. in a bullish channel2025 Support & Resistance & Consistent Profit Trading Strategies - خودرو بانک
How is Protagonist Therapeutics Inc. managing supply chain issues2025 Year in Review & Verified Momentum Stock Ideas - خودرو بانک
Using Ichimoku Cloud for Protagonist Therapeutics Inc. technicalsRate Cut & Daily Profit Maximizing Trade Tips - Newser
Applying big data sentiment scoring on Protagonist Therapeutics Inc.Market Risk Analysis & Weekly High Potential Stock Alerts - Newser
Can Protagonist Therapeutics Inc. continue delivering strong returns2025 Pullback Review & AI Powered Buy/Sell Recommendations - khodrobank.com
What momentum shifts mean for Protagonist Therapeutics Inc.Weekly Trade Summary & Daily Volume Surge Signals - Newser
Comparing Protagonist Therapeutics Inc. in custom built stock radarsTrade Risk Report & Detailed Earnings Play Alerts - Newser
Will Protagonist Therapeutics Inc. stock go up soon2025 Support & Resistance & Risk Controlled Swing Alerts - Newser
Technical analysis overview for Protagonist Therapeutics Inc. stock2025 Price Momentum & Reliable Entry Point Trade Alerts - Newser
Published on: 2025-09-04 00:44:39 - Newser
What MACD signals say about Protagonist Therapeutics Inc.Earnings Overview Report & Reliable Entry Point Alerts - Newser
How to build a custom watchlist for Protagonist Therapeutics Inc.Portfolio Gains Summary & Accurate Trade Setup Notifications - Newser
Transcript : Protagonist Therapeutics, Inc. Presents at Citi's Biopharma Back to School Conference, Sep-03-2025 09 - MarketScreener
Real time social sentiment graph for Protagonist Therapeutics Inc.Earnings Overview Summary & Community Consensus Picks - Newser
Protagonist Therapeutics to Participate in Multiple Investment Bank Conferences in September 2025 - Democrat and Chronicle
What to do if you’re stuck in Protagonist Therapeutics Inc.2025 Retail Activity & Safe Capital Growth Tips - Newser
Protagonist Therapeutics Inc. stock trendline breakdownWeekly Volume Report & Step-by-Step Swing Trade Plans - Newser
Can Protagonist Therapeutics Inc. stock outperform in a bear marketJuly 2025 Volume & AI Driven Price Predictions - خودرو بانک
Can technical indicators confirm Protagonist Therapeutics Inc.’s reversal2025 Macro Impact & Fast Entry Momentum Alerts - Newser
Has Protagonist Therapeutics Inc. formed a bullish divergencePortfolio Return Summary & Precise Buy Zone Tips - Newser
Buyback Watch: Is Protagonist Therapeutics Inc. being accumulated by smart money2025 Historical Comparison & Fast Entry and Exit Trade Plans - خودرو بانک
Combining machine learning predictions for Protagonist Therapeutics Inc.2025 Earnings Impact & Fast Moving Stock Watchlists - Newser
Protagonist Therapeutics Inc. recovery potential after sell offQuarterly Earnings Summary & High Yield Equity Trading Tips - Newser
Protagonist Therapeutics Inc (PTGX) 財務データ
収益
当期純利益
現金流量
EPS
1.96%
1.11%
大文字化:
|
ボリューム (24 時間):